House Gives Go Ahead To Drug Bill, Hurdles Remain

Law360, New York (July 12, 2007, 12:00 AM EDT) -- A bill that would renew drug user fees, strengthen drug safety and leave pediatric market exclusivity unchanged was overwhelmingly approved by the U.S. House of Representatives Wednesday night.

By a vote of 403-16, the House bill, HR 2900 or the Food and Drug Administration Amendments Act Of 2007, will next go to conference, where changes between it and a bill that passed the U.S. Senate earlier this year will be ironed out.

The legislation must be passed this session because the current bill regarding the fees...
To view the full article, register now.